Page last updated: 2024-11-03

propranolol and Developmental Disabilities

propranolol has been researched along with Developmental Disabilities in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)

Research Excerpts

ExcerptRelevanceReference
"With the diagnosis of neonatal Graves' disease established, both twins were treated with propranolol (2 mg/kg."1.30[Neonatal Basedow's disease in twins from a mother with severe T3 hyperthyroidism]. ( Grüters, A; Hüfner, M; Lakomek, M; Roth, C; Siggelkow, H, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gül, D1
Sayli, BS1
Gök, F1
Gökçay, E1
Roth, C1
Siggelkow, H1
Grüters, A1
Hüfner, M1
Lakomek, M1

Other Studies

2 other studies available for propranolol and Developmental Disabilities

ArticleYear
IgA deficiency associated with growth hormone deficiency in a boy with short arm deletion of chromosome 18 (46,XY,18p-).
    Annales de genetique, 1994, Volume: 37, Issue:2

    Topics: Arginine; Child; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 18; Developm

1994
[Neonatal Basedow's disease in twins from a mother with severe T3 hyperthyroidism].
    Deutsche medizinische Wochenschrift (1946), 1997, May-02, Volume: 122, Issue:18

    Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Autoantibodies; Developmental Disabilities;

1997